Cost-effectiveness of idelalisib in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia (Cll) in Portugal

M. Gouveia; M. G. Silva; J. Alarcão; F. Fiorentino; J. Carda; R. Costa; J. M. Mariz; J. Raposo; J. Costa; M. Borges

doi:10.1016/j.jval.2015.09.1197

Cost-effectiveness of idelalisib in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia (Cll) in Portugal

M. Gouveia
, M. G. Silva
, J. Alarcão
, F. Fiorentino
, J. Carda
, R. Costa
, J. M. Mariz
, J. Raposo
, J. Costa
, M. Borges

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	PCN180
Pages (from-to)	A461-A462
Number of pages	2
Journal	Value in Health
Volume	18
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2015.09.1197
Publication status	Published - 1 Nov 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jval.2015.09.1197Licence: Other

Cite this

Gouveia, M., Silva, M. G., Alarcão, J., Fiorentino, F., Carda, J., Costa, R., Mariz, J. M., Raposo, J., Costa, J., & Borges, M. (2015). Cost-effectiveness of idelalisib in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia (Cll) in Portugal. Value in Health, 18(7), A461-A462. Article PCN180. https://doi.org/10.1016/j.jval.2015.09.1197

@article{f7d5f95d8cb14ecebd4a13c74171ec59,

title = "Cost-effectiveness of idelalisib in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia (Cll) in Portugal",

author = "M. Gouveia and Silva, \{M. G.\} and J. Alarc{\~a}o and F. Fiorentino and J. Carda and R. Costa and Mariz, \{J. M.\} and J. Raposo and J. Costa and M. Borges",

year = "2015",

month = nov,

day = "1",

doi = "10.1016/j.jval.2015.09.1197",

language = "English",

volume = "18",

pages = "A461--A462",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "7",

}

Gouveia, M, Silva, MG, Alarcão, J, Fiorentino, F, Carda, J, Costa, R, Mariz, JM, Raposo, J, Costa, J & Borges, M 2015, 'Cost-effectiveness of idelalisib in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia (Cll) in Portugal', Value in Health, vol. 18, no. 7, PCN180, pp. A461-A462. https://doi.org/10.1016/j.jval.2015.09.1197

TY - JOUR

T1 - Cost-effectiveness of idelalisib in combination with rituximab for the treatment of relapsed/refractory chronic lymphocytic leukemia (Cll) in Portugal

AU - Gouveia, M.

AU - Silva, M. G.

AU - Alarcão, J.

AU - Fiorentino, F.

AU - Carda, J.

AU - Costa, R.

AU - Mariz, J. M.

AU - Raposo, J.

AU - Costa, J.

AU - Borges, M.

PY - 2015/11/1

Y1 - 2015/11/1

U2 - 10.1016/j.jval.2015.09.1197

DO - 10.1016/j.jval.2015.09.1197

M3 - Meeting Abstract

SN - 1098-3015

VL - 18

SP - A461-A462

JO - Value in Health

JF - Value in Health

IS - 7

M1 - PCN180

ER -